Page last updated: 2024-08-24

trovafloxacin and Critical Illness

trovafloxacin has been researched along with Critical Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lenzer, J1
Fish, DN; Olsen, KM; Rebuck, JA; Weidenbach, T1

Trials

1 trial(s) available for trovafloxacin and Critical Illness

ArticleYear
Pharmacokinetics of intravenous trovafloxacin in critically ill adults.
    Pharmacotherapy, 2000, Volume: 20, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Infective Agents; Area Under Curve; Aspartate Aminotransferases; Critical Illness; Female; Fluoroquinolones; Half-Life; Humans; Injections, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Naphthyridines; Prodrugs; Prospective Studies

2000

Other Studies

1 other study(ies) available for trovafloxacin and Critical Illness

ArticleYear
Nigerian judge orders arrests of Pfizer officials.
    BMJ (Clinical research ed.), 2008, Jan-05, Volume: 336, Issue:7634

    Topics: Anti-Infective Agents; Child; Critical Illness; Drug Industry; Fluoroquinolones; Humans; Meningitis, Bacterial; Naphthyridines; Nigeria

2008